Correlation Between RenovoRx and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Agios Pharm, you can compare the effects of market volatilities on RenovoRx and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Agios Pharm.
Diversification Opportunities for RenovoRx and Agios Pharm
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between RenovoRx and Agios is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of RenovoRx i.e., RenovoRx and Agios Pharm go up and down completely randomly.
Pair Corralation between RenovoRx and Agios Pharm
Given the investment horizon of 90 days RenovoRx is expected to generate 1.79 times more return on investment than Agios Pharm. However, RenovoRx is 1.79 times more volatile than Agios Pharm. It trades about 0.09 of its potential returns per unit of risk. Agios Pharm is currently generating about 0.14 per unit of risk. If you would invest 102.00 in RenovoRx on August 30, 2024 and sell it today you would earn a total of 24.00 from holding RenovoRx or generate 23.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
RenovoRx vs. Agios Pharm
Performance |
Timeline |
RenovoRx |
Agios Pharm |
RenovoRx and Agios Pharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RenovoRx and Agios Pharm
The main advantage of trading using opposite RenovoRx and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.RenovoRx vs. Ikena Oncology | RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Tempest Therapeutics |
Agios Pharm vs. Ikena Oncology | Agios Pharm vs. Eliem Therapeutics | Agios Pharm vs. HCW Biologics | Agios Pharm vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |